NCT02987751 - A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

December 29, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

June 30, 2019

Conditions

Type2 Diabetes

Interventions

DRUG

Glargine + Glulisine

Glargine should be taken 30 minutes before breakfast/dinner, the dose is adjusted as per fasting blood glucose during each visit and Glulisine should be taken 20 minutes before breakfast/dinner, the dose is adjusted as per postprandial blood glucose during each visit

DRUG

Premixed analogue insulin (70/30)

Premixed analogue insulin should be taken 30 minutes before breakfast/dinner, the dose is adjusted as per fasting blood glucose during each visit.

Trial Locations (8)

590010

Dr.Mallikarjnn Jali, Belagavi

600024

MedWay Hospitals, Chennai

620018

Trichy Diabetes Speciality Center (P) Ltd, Trichy

636016

M.G.Diabetes Speciality and Research Center, Salem

641009

Kovai Diabetes Speciality Center and Hospital, Coimbatore

600 019

Singhvi Health Centre, Chennai

625 020

Arthur Asirvatham Hospital, Madurai

606 603

Ramana Maharishi Rangammal Hospital, Tiruvannamalai

All Listed Sponsors

lead

India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals

OTHER